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Abstract 
Objective: Assessment of calcaneus microstructure using high-resolution peripheral 
quantitative computed tomography (HR-pQCT) might be used to improve fracture risk 
predictions or to assess responses to pharmacological and physical interventions. To develop 
a standard clinical protocol for the calcaneus, we validated calcaneus trabecular 
microstructure measured by HR-pQCT against ‘gold-standard’ micro-CT measurements. 
Methods: Ten human cadaveric feet were scanned in situ using HR-pQCT (isotropic 82 
µm voxel size) at 100, 150 and 200ms integration times, and at 100ms integration time 
following removal of the calcaneus from the foot (ex vivo). Dissected portions of these bones 
were scanned using micro-computed tomography (micro-CT) at an isotropic 17.4 µm voxel 
size. HR-pQCT images were rigidly registered to those obtained with micro-CT and divided 
into multiple 5mm sided cubes to evaluate and compare morphometric parameters between 
the modalities. Standard HR-pQCT measurements (derived bone volume fraction (BV/TVd); 
trabecular number, Tb.N; derived trabecular thickness, Tb.Thd; derived trabecular spacing, 
Tb.Spd) and corresponding micro-CT voxel-based measurements (BV/TV, Tb.N, Tb.Th, Tb.Sp) 
were compared.  
Results: A total of 108 regions of interest were analysed across the 10 specimens. At all 
integration times HR-pQCT BV/TVd was strongly correlated with micro-CT BV/TV (r2 = 0.95-
0.98, RMSE = 1%), but BV/TVd was systematically lower than that measured by micro-CT 
(mean bias = 5%). In contrast, HR-pQCT systematically overestimated Tb.N at all integration 
times; of the in situ scans, 200ms yielded the lowest mean bias and the strongest correlation 
with micro-CT (r2 = 0.61, RMSE = 0.15 mm-1). Regional analysis revealed greater accuracy for 
Tb.N in the superior regions of the calcaneus at all integration times in situ (mean bias = 0.44-
0.85 mm-1; r2 = 0.70-0.88, p<0.001 versus mean bias = 0.63-1.46 mm-1; r2 < 0.10, p0.21 for 
inferior regions). Tb.Spd was underestimated by HR-pQCT compared to micro-CT, but showed 
similar trends with integration time and the region evaluated as Tb.N. HR-pQCT Tb.Thd was 
also underestimated (mean bias = 0.081-0.102 mm) and moderately correlated (r2 = 0.55-0.59) 
with micro-CT Tb.Th, independently from the integration time. Stronger correlations, smaller 
biases and error were found in the scans of the calcaneus ex vivo compared to in situ. 
Conclusion: Calcaneus trabecular BV/TVd and trabecular microstructure, particularly in the 
superior region of the calcaneus, can be assessed by HR-pQCT. The highest integration time 
examined, 200ms, compared best with micro-CT. Weaker correlations for microstructure at 
inferior regions, and also with lower integration times, might limit the use of the proposed 
protocol, which warrants further investigation in vivo. 
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1. Introduction 
Osteoporosis is characterized by a deterioration of bone mass and microstructure, resulting in 
loss of bone strength and increased risk of fracture [1]. Dual-energy x-ray absorptiometry 
(DXA) areal bone mineral density (BMD) is used as part of the routine assessment of 
osteoporosis, either alone or increasingly combined with an evaluation of risk factors 
independent of BMD as in tools such as FRAX [2]. The two-dimensional representation of bone 
properties captured by DXA measurements limits the technique’s sensitivity to changes in 
bone microstructure with disease and with treatments for osteoporosis management. Clinical 
research studies have recently benefitted from being able to study bone microstructure using 
a significantly lower ionizing radiation dose and higher spatial resolution compared to standard 
quantitative computed tomography (QCT) at the spine and hip [3]. Such High-Resolution 
peripheral QCT (HR-pQCT) can identify trabecular and cortical microstructural abnormalities 
and mechanical deficiencies associated with fracture risk [4-6], and appears sensitive to 
changes induced by some treatments for osteoporosis [7-9].  
The HR-pQCT scan has been performed primarily at the distal radius and distal tibia. Other 
sites have been scanned using HR-pQCT, such as the metacarpal joints [10, 11] and there 
have been new developmental investigations at the knee [12]; these highlight quantitative 
outcomes that could be useful in areas other than osteoporosis research. The calcaneus (heel 
bone) has been widely investigated in osteoporosis, particularly using the attenuation of 
ultrasonic waves from quantitative ultrasound (QUS). The latter appears to provide 
microstructural information independent of BMD [13, 14] and can predict vertebral and non-
vertebral fracture risk [15]. However, there have been validity issues using QUS, specifically 
associated with its precision over time [16] and inter-device differences [17]. DXA scanning 
could be used in the calcaneus, however this would still suffer from the inherent limitations of 
areal measurements. In podiatry research, clinical computed tomography (CT) has been used 
to model the calcaneus and surrounding bones of the foot [18, 19] and to clinically examine 
calcaneal fractures. In the assessment of calcaneus microstructure, measurements from 
multidetector CT scans, with an in-plane pixel size of 208 µm and 500 µm slice thickness, have 
been weakly correlated (r2
 0.51) to measurements from micro-CT scans (16 µm voxel size) 
[20]. The use of HR-pQCT scans with a voxel size of 61 to 82 µm may improve the 
quantification of calcaneus microstructure in vivo and could therefore be of interest to the 
osteoporosis and podiatry fields; to our knowledge a method to scan the calcaneus using HR-
pQCT has not been reported in vivo. 
Distal radius and tibia trabecular and cortical microstructural and biomechanical HR-pQCT 
measurements have been validated in comparison to scans obtained using micro-CT [21-25]. 
Compared to the radius and tibia, the calcaneus is anatomically and structurally different; it is 
the largest tarsal bone and has several close-lying bones of the foot (talus, navicular and 
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cuboid). Additionally, it is characterized by a thin cortex containing trabecular bone. We 
therefore aimed to develop a protocol to scan the calcaneus using HR-pQCT, and to validate 
measurements of trabecular microstructure. Specifically, we wanted to determine the accuracy 
of trabecular bone volume fraction and microstructure in calcaneus HR-pQCT scans with 
respect to gold standard micro-CT measurements, and to explore the impact of scan 
integration time (i.e. the duration that each tomographic projection was exposed to the X-ray 
source) on structural parameters. 
2. Methods 
2.1. Materials 
Ten lower limbs were obtained from cadavers (n=5, all female, age range 85 to 101 years) that 
had consented in life and were donated to the University of Sheffield for anatomical study. The 
cadavers had undergone standard embalming, which has been reported to have a minimal 
effect on BMD [26], and the limbs were divided through the proximal 2/3 point of the tibia. The 
use of the limbs was carried out under direct supervision of the Designated Individual, 
authorised under the Human Tissue Act and the limbs were returned after use. No medical 
history was available and specimens were not examined for the presence of metabolic bone 
disease. Ethical approval was provided by the Medical School Research Ethics Committee at 
the University of Sheffield (reference number 007375). 
2.2. HR-pQCT scanning 
The embalmed specimens were kept in sealed polythene bags during HR-pQCT scanning. 
Specimens were positioned in the carbon fiber foot cast that is normally used for the distal tibia 
HR-pQCT scan. The feet were positioned so that the superior and inferior surfaces of the 
calcaneus were parallel to the reference line that was positioned to start the scan: this enabled 
a series of lateral slices of the calcaneus to be obtained. In vivo, this would require a body and 
lower-limb position equivalent to the distal tibia HR-pQCT scan, but with plantar-flexion at the 
ankle. Scans of the whole calcaneus were obtained between the superior peak of the 
tuberosity and the plantar fascia attachment to the calcaneal tuberosity at an isotropic voxel 
VL]HRIȝP(maximum of 660 slices) using the standard clinical operational settings: 60 kVp 
and 95 mA collecting 750 projections over a 180° rotation of the x-ray source (XtremeCT I, 
SCANCO Medical AG; Brüttisellen, Switzerland). As part of the method development, each 
calcaneus was scanned with different integration times; in situ (with the calcaneus in the intact 
limb) scan projections were collected twice at 100ms and once each at 150 and 200ms 
integration times, labelled IS100, IS150 and IS200, respectively. The range of integration times 
was tested to determine the potential gains in microstructure assessment of more prolonged 
exposure, while limiting the upper scan time to 4.2 minutes to minimize potential movement 
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artifacts when the protocol would be used in vivo in future clinical settings. Isolated (ex-vivo, 
with the calcaneus removed from the limb, soft tissue removed but no cleaning of the bone 
marrow) scan projections were collected at 100ms integration time, labelled EV100, to 
determine whether measurements would be affected by the surrounding bones of the foot. For 
these scans, the calcaneal samples were placed in sealed polythene bags and supported by 
foam, in order to obtain a similar anatomical position to scans in situ. 
Image reconstruction followed the manufacturer’s standard methods. The reconstructed linear 
attenuation was mapped onto a 1536x1536 matrix and converted to hydroxyapatite (HA) 
densities. Calibrations of the densities were performed on a daily basis using a phantom 
supplied by the manufacturer, which has HA rods at 0, 100, 200, 400 and 800 mg HAcm-3 
embedded in resin.  
2.3. Micro-CT scanning 
The dissected calcanei were cut into rectangular prism samples (18x18x40 mm) preserving 
cortical bone at the superior and inferior surfaces, using a diamond-coated bandsaw under 
constant water irrigation (EXAKT, GmbH; Norderstedt, Germany). Each sample was 
submerged and fixed in a 50ml holder containing saline solution and was vacuumed for 20 
minutes to remove air bubbles prior to each scan. 
Each sample was scanned at an isotropic voxel size of 17.4 µm using a SkyScan 1172 desktop 
micro-CT system (Brüker; Kontich, Belgium). Settings for image acquisition were 100 kV, 100 
µA, 2950ms integration time, 2 frames averaged, 1.0 mm aluminum filter and a 0.7° rotation 
step. Scans were reconstructed using the NRECON software, according to the manufacturer’s 
recommendations: ring artifact was set to 10, beam hardening to 30%, 16-bit DICOMs as 
applied in a recent study of human trabecular bone [27].  
2.4. Rigid image registration 
HR-pQCT scan DICOMs were registered to their respective micro-CT scans in a two-step 
process (Amira 6.0, FEI; Oregon, USA): step 1, an IS100 HR-pQCT scan was pre-aligned and 
registered to the micro-CT scan using a normalized mutual information metric and resampled 
using a Lanczos interpolator. The Lanczos interpolator has been applied to transform micro-
CT scans of small animals [28, 29]. A preliminary study showed minimal effects of Lanczos 
interpolation when applied to HR-pQCT scans (Supplemental material 1). In step 2, the 
remaining HR-pQCT scans (IS100, IS150, IS200 and EV100) were registered using similar 
settings to the pre-registered IS100 HR-pQCT scan. This spatially registered all HR-pQCT 
scans to the micro-CT scan and, importantly, to the same reference system. The HR-pQCT 
scans from step 2 were used for morphological evaluation. 
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2.5. HR-pQCT and micro-CT evaluation 
A custom cropping procedure was performed at the common region between the scan 
modalities, along the superior-inferior axis. The aim of the procedure was to increase the 
likelihood of evaluating a wider range of BV/TV [25, 30] as there had been significant bone 
loss in some specimens. Images were divided into regions of interest approximately 5x5x5mm 
in dimensions: HR-pQCT, 60x60x60 voxels and micro-CT 284x284x284 voxels (Figure 1). 24 
cubical regions of trabecular bone were isolated in each scan, virtually dividing the central 
portion of each micro-CT image in six 5mm thick slices, which were divided into four cubes 
(Figure 1). All registered HR-pQCT scans and the micro-CT scans were then imported into an 
XtremeCT workstation and evaluated using the SCANCO Image Processing Language (IPL 
5.08-B). 
 
A 
 
3D rigid registration Sagittal Transverse Coronal 
B 
 
Figure 1. Methodology for registration and identifying the cubed regions of interest for HR-
pQCT and micro-CT image analysis. 
A) The HR-pQCT images were rigidly registered to the micro-CT image (red). Examples of the micro-
CT and HR-pQCT images following transformation are shown in all 3 planes (sagittal, transverse and 
coronal). 
B) Scans were split into six 10x10x5mm regions along the superior-inferior axis. The 6 regions were 
sub-divided into four equal sized cubed volumes of interest (5x5x5 mm), which were used in the 
evaluations. Two of the 10x10x5 mm regions were combined into superior, middle and inferior 
regions: there were eight 5x5x5 mm-cubed volumes of interest in these regions. 
Superior = region 1 to 8; middle = region 9 to 16; inferior = region 17 to 24. 
 
HR-pQCT scans were evaluated using the standard patient analysis; this uses a Laplace-
Hamming filter to smooth the image and enhance edges, and then applies a 40% fixed global 
threshold to segment the bone from marrow phase [31]. From the segmented images the 
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following measurements were extracted: trabecular volumetric bone mineral density 
(Tb.vBMD), derived trabecular bone volume/total volume (BV/TVd; Tb.vBMD/1200), trabecular 
number (Tb.N) using ridge extraction methods [32] and derived trabecular thickness (Tb.Thd; 
BV/TVd/Tb.N) and spacing (Tb.Spd; (1-BV/TVd)/Tb.N) using plate-model assumptions [33, 34].  
Micro-CT scans underwent a Gaussian filter (kernel 1.2, support 2) to reduce the high 
frequency noise and were segmented using a single-level, global threshold (330/1000) based 
on a visual inspection of each specimen. Four individual regions from the same specimen had 
an adapted threshold (350/1000) after visually checking the segmented scan images. A 
despeckle algorithm was applied to remove isolated bone regions with a volume lower than 10 
voxels. BV/TV was determined by dividing the number of bone voxels by the total number of 
voxels in the region of interest (TV). Trabecular microstructure (Tb.N, Tb.Th and Tb.Sp) were 
calculated using the distance transformation method, where maximal spheres are filled into 
the segmented image [35]. Examples of the HR-pQCT and micro-CT scans segmentation are 
presented in Figure 2. 
2.6. Statistical analysis 
Statistical analyses were completed in GraphPad Prism (7.0, GraphPad Software: La Jolla 
California, USA) and R Studio (1.0.44: Boston, USA). A p<0.05 indicated statistical 
significance, unless stated otherwise. Morphometric measurements were non-normally 
distributed following visual and statistical checks (Shapiro-Wilk test), therefore median and 
interquartile ranges were calculated for each measurement. Wilcoxon-Rank tests were 
performed to compare the paired HR-pQCT and micro-CT scans (IS100, IS150, IS200, EV100 
vs. micro-CT). Friedman’s test was performed to compare the four HR-pQCT scans, with post-
hoc between-pair analyses using Dunn’s multiple comparisons test with Bonferroni corrections 
(p<0.017). 
Linear regression analyses were performed to evaluate the correlation between the 
measurements performed on the HR-pQCT and micro-CT images; coefficient of determination 
(r2), equation slope and intercept, root mean square error (RMSE) and the largest difference 
between the predicted and morphological parameters (max. error) were calculated. A region 
was treated as an outlier and removed from the regression analyses if all comparisons (IS100, 
IS150, IS200 and EV100) exceeded the Cook’s distance (4/number of regions). Regression 
slopes were compared between the HR-pQCT scans using a one-way ANOVA and t-tests with 
Bonferroni corrections, to account for multiple tests i.e. between scan conditions (0.05/4) and 
between regions (0.05/3). Bland-Altman methods were performed to test for bias (mean±SD) 
between the paired HR-pQCT scans and the micro-CT scan [36]. 
 
IS100 IS150 IS200 EV100 Micro-CT 
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Figure 2. Segmentation of representative regions of interest in the calcaneus using 
HR-pQCT and micro-CT. 
A slice is shown for a representative HR-pQCT and micro-CT image. The HR-pQCT scan 
is separated into the condition (in situ (IS) and ex vivo (EV)) and scan integration time (100, 
150 and 200ms). This includes a grayscale and segmented slice, and the 3D volume of 
interest. 
3. Results 
3.1. Descriptive comparisons 
In total, 108 matched regions were evaluated between all HR-pQCT scans and the micro-CT 
scans, after removal of HR-pQCT scans with visible air bubbles or negative Tb.vBMD values. 
Table 1 contains the descriptive statistics for the morphological measurements from the scans. 
All estimates of BV/TVd, Tb.Thd and Tb.Spd derived from HR-pQCT images (IS100, IS150, 
IS200 and EV100) were significantly lower than the corresponding measures obtained from 
micro-CT images (all p<0.001). In contrast, Tb.N measured in all HR-pQCT images was 
significantly overestimated (p<0.001) when compared to the micro-CT measurements. No 
differences were found among the Tb.vBMD and BV/TVd measurement performed on the in 
situ HR-pQCT images across the 3 integration times, but Tb.N, Tb.Thd and Tb.Spd measured 
from IS100, IS150 and IS200 images were all significantly different to one another (p<0.001); 
as the integration time increased, Tb.N decreased and Tb.Thd and Tb.Spd increased. 
Tb.vBMD, BV/TVd and Tb.N measured from the in situ HR-pQCT images were significantly 
higher, and Tb.Spd were significantly lower, compared to the measurements from the EV100 
HR-pQCT image (p<0.001). Tb.Thd measured from the IS100 and IS150 was significantly 
lower than measurements from the EV100 HR-pQCT image (p<0.001), but there was no 
difference between the IS200 and EV100 measurement. 
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3.2. Regression analyses in the common whole sample 
Regression analyses for all evaluable regions are shown in Table 2. There were strong 
correlations between BV/TV measured in the micro-CT images and BV/TVd computed from 
both in situ and ex vivo HR-pQCT images (r2 = 0.95-0.98). There was no difference between 
the BV/TV versus BV/TVd regression slopes (p=0.94) and the RMSEs were similar (0.8-0.9%). 
The BV/TVd maximum errors obtained from the in situ HR-pQCT images were similar (2-2.3%), 
and the value measured from the ex vivo HR-pQCT image was apparently lower (1.4%). 
Weak to moderate correlations were found between Tb.N measured in the micro-CT and the 
in situ HR-pQCT images; the correlations were dependent on integration time (r2 = 0.33 for 
IS100 and r2 = 0.61 for IS200) with significant differences between the IS100 and IS200 
regression slopes (p<0.01). There seemed to be lower RMSE and maximum error when the in 
situ integration time was increased from IS100 to IS200 (0.19 to 0.15 mm-1 and 0.67 to 0.46 
mm-1, respectively). The Tb.N correlation improved further when measured by the ex vivo HR-
pQCT image in comparison to the micro-CT image (r2 = 0.79) and the regression slope was 
significantly different to that obtained with the in situ comparisons (IS100, IS150 and IS200, 
p<0.001). Tb.N measured from the ex vivo HR-pQCT image also seemed to have lower RMSE 
(0.11 mm-1) and maximum error (0.30 mm-1) compared measurements from the in situ HR-
pQCT images.  
Moderate correlations were found for Tb.Thd estimated in all HR-pQCT images with respect to 
the respective micro-CT measurements (r2 = 0.53-0.59). There were no significant differences 
between the Tb.Thd regression slopes (p=0.73), and the RMSE and maximum error were all 
similar between the different HR-pQCT integration times. Weak to moderate correlations were 
Table 1. Descriptive statistics for the micro-CT and HR-pQCT scan images. 
Measurements Micro-CT HR-pQCT IS200 IS150 IS100 EV100 
Tb.vBMD 
(mg HA/cm3) 
- 102c 
(64, 132) 
104c 
(67, 127) 
104c 
(64, 131) 
99 
(61, 132) 
BV/TV (%) 13.6 
(10.2, 16.2) 
8.7c 
(5.4, 10.7) 
8.7c 
(5.5, 10.6) 
8.7c 
(5.4, 10.9) 
8.2 
(5, 11) 
Tb.N (mm-1) 1.49 
(1.37, 1.62) 
1.98c 
(1.72, 2.44) 
2.14bc 
(1.84, 2.89) 
2.51abc 
(2.24, 3.32) 
1.79 
(1.48, 1.97) 
Tb.Th (mm) 0.128 
(0.119, 0.135) 
0.044 
(0.028, 0.053) 
0.040bc 
(0.025, 0.05) 
0.034abc 
(0.02, 0.046) 
0.046 
(0.029, 0.056) 
Tb.Sp (mm) 0.64 
(0.56, 0.7) 
0.46c 
(0.38, 0.55) 
0.42bc 
(0.33, 0.49) 
0.36abc 
(0.28, 0.41) 
0.51 
(0.45, 0.62) 
Abbreviations: in situ 100ms (IS100); in situ 150ms (IS150); in situ 200ms (IS200); ex vivo 100ms 
(EV100); trabecular vBMD (Tb.vBMD), bone volume fraction (BV/TV), trabecular number (Tb.N), 
trabecular thickness (Tb.Th), trabecular spacing (Tb.Sp). 
N = 108 matched regions. Data are presented as median (25%, 75% percentile). Shaded areas 
indicate measurements that were directly measured. 
Measurements in bold are significantly different to all HR-pQCT scans (all p<0.001). 
a
 different to IS150, b different to IS200, c different to EV100 (all p<0.001). 
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found for Tb.Spd estimated in all HR-pQCT images with respect to Tb.Sp micro-CT 
measurements; in situ correlations were dependent on the integration time (r2 = 0.33 for IS100 
and r2 = 0.55 for IS200) and the correlation was found to increase when measured in the ex 
vivo HR-pQCT image (r2 = 0.68). There were no differences in Tb.Spd regression slopes 
(p=0.64), and the Tb.Spd RMSE and maximum error were all similar. 
 
Table 2. Regression analysis for the HR-pQCT vs. Micro-CT trabecular 
measurement across all regions. 
Sample r2 Intercept Slope RMSE Max. error 
Bone volume/total volumed (%) (n=104) 
IS200 0.96 0.050 1.000 0.009 0.021 
IS150 0.95 0.050 1.010 0.009 0.023 
IS100 0.96 0.050 1.000 0.008 0.020 
EV100 0.98 0.053 1.020 0.008 0.014 
Trabecular number (mm-1) (n=106) 
IS200 0.61 0.805 0.347§ 0.15 0.46 
IS150 0.44 0.921 0.263§ 0.18 0.59 
IS100 0.33 0.941 0.217*§ 0.19 0.67 
EV100 0.79 0.678 0.469 0.11 0.30 
Trabecular thicknessd (mm) (n=107) 
IS200 0.55 0.103 0.588 0.009 0.025 
IS150 0.53 0.104 0.607 0.010 0.026 
IS100 0.55 0.106 0.663 0.009 0.023 
EV100 0.59 0.102 0.586 0.008 0.022 
Trabecular spacingd (mm) (n=107) 
IS200 0.55 0.367 0.556 0.07 0.21 
IS150 0.43 0.401 0.530 0.08 0.23 
IS100 0.33 0.402 0.627 0.09 0.24 
EV100 0.66 0.348 0.517 0.06 0.21 
Abbreviations: in situ 100ms (IS100); in situ 150ms (IS150); in situ 200ms (IS200); 
ex vivo 100ms (EV100); RMSE, root mean square error; max. error, maximum error 
from the regression equation. 
All r2 are statistically significant, p<0.001. Comparison of regression slopes between 
different HR-pQCT conditions: * significant difference to IS200, 
p<0.01; § significantly different to EV100, p<0.001 
 
3.3. Regression analysis in superior, middle and inferior regions of the calcaneus. 
We completed a regional analysis by grouping the 5 mm3 regions of interests into superior, 
middle and inferior regions of the calcaneal samples (Figure 1). A number of cubed regions 
from the inferior region were removed as the analysis returned a negative vBMD. The results 
within each of these regions for BV/TVd and Tb.N, the measurements used to compute Tb.Thd 
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and Tb.Spd from the HR-pQCT images, are shown in Tables 3 and 4, respectively, with 
corresponding regression plots in the supplemental material 2. Data for Tb.Thd and Tb.Spd are 
shown in the supplemental material 2 to 4. 
BV/TV measured by micro-CT or BV/TVd estimated by HR-pQCT were highest in the superior 
region of the calcaneus in comparison to the middle and inferior regions (p<0.01 for all images), 
but were not statistically significant between the middle and inferior regions (micro-CT, p=0.13; 
HR-pQCT, p=0.16-0.29)(Table 3). There were strong correlations at the superior, middle and 
inferior regions for BV/TV measured in the micro-CT images and BV/TVd computed from both 
in situ and ex vivo HR-pQCT images (r2 = 0.96-0.99, all p<0.001). The superior and middle 
region regression slopes for BV/TVd were significantly different to the inferior region, within 
each respective integration time in situ (p<0.017). The BV/TVd RMSE was below 1% in all 
regions. The maximum error was 1-2% for the in situ and ex vivo HR-pQCT images at the 
superior, middle and inferior regions. 
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Tb.N measured by micro-CT was significantly higher in the superior and middle region 
compared to the inferior region (p=0.02 and p=0.03, respectively)(Table 4). A similar 
relationship was found for Tb.N measured from the ex vivo HR-pQCT images (p=0.003 and 
p=0.005, respectively). In contrast, Tb.N measured from the in situ images appeared to 
increase from the superior to inferior region, though these values were largely not significantly 
different between the regions, apart from Tb.N being significantly higher in the inferior region 
compared to the superior region in the IS100 HR-pQCT images (p=0.03).  
The correlation for Tb.N measured from micro-CT and HR-pQCT images was strongest in the 
superior region (r2 = 0.70-0.93, all p<0.001) compared to the middle region (r2 = 0.52-0.73, all 
p<0.001). No correlation was found for Tb.N in the inferior region (all p0.21). The strongest 
correlations were found for Tb.N measured in the ex vivo HR-pQCT compared to the micro-
Table 3. Bone volume fraction regression data for the different HR-pQCT conditions 
at the three different regions. 
Sample Median (IQR) r2 Intercept Slope RMSE Max. error 
Superior (n=42) 
Micro-CT 0.159 (0.139, 0.187)      
IS200 0.105 (0.081, 0.126) 0.96 0.069 0.862§ 0.009 0.018 
IS150 0.103 (0.083, 0.124 0.96 0.070 0.857§ 0.009 0.019 
IS100 0.105 (0.084, 0.124) 0.97 0.066 0.880§ 0.008 0.019 
EV100 0.102 (0.082, 0.130) 0.97 0.063 0.927*§ 0.007 0.020 
Middle (n=43) 
Micro-CT 0.125 (0.097, 0.153)      
IS200 0.078 (0.046, 0.103) 0.96 0.053 0.954§ 0.007 0.020 
IS150 0.077 (0.046, 0.102) 0.96 0.052 0.962§ 0.008 0.022 
IS100 0.077 (0.044, 0.100) 0.96 0.053 0.967§ 0.007 0.021 
EV100 0.071 (0.044, 0.095) 0.99 0.051 1.030 0.004 0.013 
Inferior (n=21) 
Micro-CT 0.100 (0.075, 0.123)      
IS200 0.056 (0.036, 0.075) 0.98 0.035 1.160 0.005 0.010 
IS150 0.058 (0.036, 0.075) 0.98 0.033 1.180 0.005 0.012 
IS100 0.056 (0.035, 0.074) 0.98 0.035 1.160 0.005 0.010 
EV100 0.05 (0.025, 0.071) 0.99 0.049 1.070 0.004 0.008 
Abbreviations: in situ 100ms (IS100); in situ 150ms (IS150); in situ 200ms (IS200); ex vivo 
100ms (EV100); RMSE, root mean square error; max. error, maximum error from the 
regression equation. 
Median (interquartile range) bone volume fraction (1) is presented within each integration 
time at each region.  
r2 in bold are statistically significant, p<0.001. Comparison of regression slopes between 
the regions, within the same integration time: * p<0.017 compared to the middle region; § 
p<0.017 compared to the inferior region.  
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CT image, and was the only HR-pQCT image to be significantly, albeit moderately, correlated 
with micro-CT in the inferior region. All superior region regression slopes were significantly 
different to the middle and inferior regions, within each respective integration time, and the 
middle region regression slopes were significantly different to the inferior region. A lower 
RMSE and maximum error were apparent at the superior and middle region with increasing 
integration time in situ, but this was not apparent at the inferior region in situ.  
 
 
3.4. Bland-Altman method comparison 
Bland-Altman plots, for measurements in the superior, middle and inferior regions, are 
presented for BV/TVd and Tb.N in Figure 3. Plots for Tb.Thd and Tb.Spd are available in the 
supplemental material 5. BV/TVd computed from the HR-pQCT images underestimated BV/TV 
measured by micro-CT. The mean biases for the in situ and ex vivo HR-pQCT images were 
similar between the integration times and regions: approximately 4 to 5%. Tb.N measured by 
Table 4. Trabecular number regression data for the different HR-pQCT 
conditions at the three different regions. 
Sample Median (IQR) r2 Intercept Slope RMSE Max. error 
Superior (n=41) 
Micro-CT 1.51 (1.37, 1.65)      
IS200 1.87 (1.64, 2.10) 0.88 0.565 0.499*§ 0.10 0.20 
IS150 2.02 (1.79, 2.28) 0.82 0.601 0.454*§ 0.12 0.28 
IS100 2.36 (1.95, 2.59) 0.70 0.632 0.385§ 0.16 0.38 
EV100 1.81 (1.55, 1.98) 0.93 0.461 0.584*§ 0.07 0.17 
Middle (n=44) 
Micro-CT 1.56 (1.37, 1.67)      
IS200 1.99 (1.67, 2.56) 0.70 0.860 0.317§ 0.12 0.27 
IS150 2.13 (1.89, 2.96) 0.59 0.916 0.264§ 0.15 0.35 
IS100 2.49 (2.29, 3.44) 0.52 0.822 0.258§ 0.16 0.38 
EV100 1.86 (1.51, 2.07) 0.76 0.680 0.460§ 0.11 0.24 
Inferior (n=21) 
Micro-CT 1.45 (1.32, 1.47)      
IS200 2.06 (1.88, 2.36) 0.00 1.430 -0.013 0.10 0.22 
IS150 2.34 (2.19, 2.85) 0.05 1.510 -0.044 0.10 0.21 
IS100 2.87 (2.61, 3.30)  0.08 1.560 -0.054 0.10 0.20 
EV100 1.69 (1.13, 1.79) 0.50 1.110 0.196 0.07 0.20 
Abbreviations: in situ 100ms (IS100); in situ 150ms (IS150); in situ 200ms (IS200); ex 
vivo 100ms (EV100); RMSE, root mean square error; max. error, maximum error from 
the regression equation. 
Median (interquartile range) trabecular number (mm-1) is presented within each 
integration time at each region. 
r2 in bold in all regions are statistically significant, p0.001. Comparison of regression 
slopes between the regions, within the same integration time: * p<0.017 compared to 
the middle region; § p<0.017 compared to the inferior region. 
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HR-pQCT images systematically overestimated Tb.N measured from the micro-CT images. 
The mean bias for Tb.N decreased as the integration time increased in the in situ HR-pQCT 
images at all regions. The Tb.N mean bias was lower in the ex vivo HR-pQCT images 
compared to the in situ HR-pQCT images. The mean bias (±SD) for IS100 and IS150 increased 
from the superior to inferior regions (IS100: superior = -0.85±0.40 mm-1, inferior = -1.46±0.55 
mm-1; IS150: superior = -0.56±0.33 mm-1, inferior = -0.98±0.53 mm-1), whereas the mean bias 
for the IS200 HR-pQCT image increased from the superior to middle and was similar for the 
middle to inferior regions (superior = -0.44±0.28 mm-1, middle = -0.58±0.42 mm-1, inferior = -
0.63±0.41 mm-1).   
 
Figure 3. Bland-Altman plots for calcaneus bone volume fraction and trabecular number 
measured from HR-pQCT images compared to micro-CT image at different regions. 
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Abbreviations: in situ 100ms (IS100); in situ 150ms (IS150); in situ 200ms (IS200); ex vivo 100ms 
(EV100). 
The mean (SD) bias is shown for bone volume/total volume and trabecular number, within each region 
(superior, middle and inferior) and in each HR-pQCT scan condition (IS100, IS150 and IS200, and 
EV100). 
4. Discussion 
This study describes the novel adaptation of HR-pQCT for the measurement of calcaneal 
BV/TVd and microstructure. Calcaneus BV/TVd and microstructure assessed at an isotropic 82 
µm voxel size was validated against micro-CT at an isotropic 17 µm voxel size, which acted as 
a gold-standard reference. HR-pQCT BV/TVd had a strong correlation across all scan 
conditions, explaining 95 to 98% of micro-CT BV/TV, when all regions were combined. This is 
important, as BV/TVd is a key measurement to predict bone strength [21, 22, 37] and has a 
strong association with fracture risk [4, 6].  
The strong correlation and underestimation of BV/TVd that was found with the calcaneus HR-
pQCT scan images was consistent with previous studies at the distal radius and distal tibia 
[22-24]. The lower estimation of BV/TVd, derived from Tb.vBMD measurement by HR-pQCT, 
could be caused by the global threshold used to define bone tissue and lower signal to noise 
ratio resulting in a higher number of partial volume voxels in the HR-pQCT images compared 
to the micro-CT images. It should also be remembered that the HR-pQCT measurements were 
made in the intact bone, so that beam hardening artifacts caused by the intact cortex and 
surrounding bone structures may have also impacted on Tb.vBMD measurement [38]. 
Trabecular vBMD was similar at the different integration times. On removing the calcaneus 
from the foot, the trabecular vBMD and BV/TVd were significantly lower than the in situ scans, 
even though the absolute difference was relatively small. Dissection may have exposed the 
calcaneus to air bubbles that were undetectable in the HR-pQCT images, or else there may 
have been a reduction in image noise with removal of the surrounding bones and soft tissue. 
Nonetheless, a regression equation that is independent of integration time can be used to 
adjust calcaneus BV/TVd computed from HR-pQCT images to that measured by micro-CT (Y 
= 1.010*X + 0.050). 
Calcaneus Tb.N was systematically overestimated, and Tb.Thd and Tb.Spd subsequently 
underestimated when measured by HR-pQCT using the standard patient analysis, consistent 
with previous studies at the radius and tibia [22-24]. It has been well established that the 
accurate measurement of trabecular microstructure is dependent on the spatial resolution [23], 
which was equivalent to the calcaneus Tb.Th measured by micro-CT in the current study. The 
higher values of Tb.N in purely trabecular samples measured by HR-pQCT compared to micro-
CT are in keeping with previous reports [22, 23], probably reflecting factors such as decreased 
signal to noise ratio and partial volume effects, factors that are exacerbated at the shorter 
integration times as observed in our study.  A similar increase in Tb.N for individual specimens 
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has been reported when comparing a 123 ȝPWR82 ȝPLVRWURSLFYR[HOVL]H[23].  BV/TVd may 
be less susceptible to such factors as it is derived from Tb.vBMD, in which the averaging per 
cm-3 is likely to suppress differences between integration times, as has been demonstrated 
with direct BV/TV measurement [21, 25, 39]. 
The direct measurement of Tb.N is fundamental to determining Tb.Spd and Tb.Thd using plate-
model assumptions. The HR-pQCT indirect patient analysis aims to preserve all trabeculae 
using a low global threshold in order to measure Tb.N [40]. The caveat is that if an image has 
a low signal-to-noise ratio, image noise could be categorised as bone following application of 
the HR-pQCT threshold to segment to bone and marrow phases [31]; this is the possible 
mechanism of the greater overestimation of Tb.N at lower integration times and in the inferior 
regions of the calcaneus. Increasing integration time improved the accuracy of Tb.N in 
comparison to micro-CT, leading also to an improvement in Tb.Spd accuracy. However, Tb.Thd 
was not improved, due to its equal-weighted dependency on BV/TVd and Tb.N; weak 
correlations with Tb.Thd have been confirmed in studies at the radius and tibia despite strong 
correlations for BV/TVd and Tb.N [23, 24]; this study therefore further highlights a limitation in 
the use of the plate-model assumptions using the first generation XtremeCT. A better signal-
to-noise ratio, provided by a higher Tb.BMD, was also reflected in the improved accuracy of 
Tb.N in the denser superior region of the calcaneus than in the middle and, particularly, inferior 
regions. Furthermore, the regions with thinner trabeculae (middle and inferior) could be more 
susceptible to errors with the global threshold applied by the indirect HR-pQCT analysis, which 
could also explain differences in trabecular measurement accuracy compared to other studies 
[21-24, 40].  Other thresholds may improve the accuracy; for example, in femoral head 
trabecular bone samples a local-derived direct assessment improved estimates of trabecular 
thickness and spacing, though the overall  impact was relatively small [40].. 
The superior region scanned at 200ms integration time had comparable correlation, slopes 
and accuracy for BV/TVd, Tb.N and Tb.Spd compared to previous studies at the distal radius 
and distal tibia [22-24]. This is encouraging, as these validated protocols have been widely 
used in clinical studies [4-9]. In addition to lower bone volume in the middle and inferior regions, 
the signal-to-noise ratios may also be impacted by the surrounding bones of the foot at these 
levels in affecting the measurement of trabecular microstructure using HR-pQCT. The more 
marked differences in Tb.N between the in situ and ex vivo scans at the inferior region suggest 
that this may be the case. In the same region, noise is likely to have contributed to the fact that 
although the ex vivo scan had similar Tb.N values to the micro-CT, the correlation was still 
relatively weak. Additionally, the poorer estimation at these regions could be due to thinner 
trabeculae, which has been highlighted as an issue in a previous study comparing plate- and 
rod-like trabeculae at different voxel sizes [41].  
The results reinforce using 200ms integration time for the calcaneus HR-pQCT scans to 
compensate for the x-ray absorption from the surrounding tissues. Practically, there would still 
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be a low radiation exposure per 110 slices ȝ6YSHUVFDQ). However, scan duration would be 
4.2 minutes (per 110 slices using the XtremeCT I), which is longer than the distal radius and 
distal tibia scans (2.8 minutes), and would increase the probability of participant movement 
and may consequently affect measurement precision error. Precision error of HR-pQCT 
measurements at the calcaneus has not been established in vivo. Distal radius and tibia error 
is already between 3 to 6% (least significant change 8 to 17%) for trabecular microstructure 
using rigid registration at 100ms integration time [42-44]. However, it can be questioned 
whether the accuracy at lower integration times could be accepted to improve reproducibility, 
which could be the case if BV/TVd, and possibly other volumetric measurements, were of 
primary interest. The comparison of different integration times in vivo therefore requires 
investigation.  
We have attempted to best represent in vivo conditions by obtaining HR-pQCT scans in situ, 
with bones, soft tissue and marrow intact, to inform the clinical translation of the method. 
However, we recognize there are several limitations to the study. First, and as has been 
discussed, the study was free from movement artifact, which would be expected to affect 
measurement accuracy in vivo. Second, measurements may have been impacted by the 
deterioration of bone mineral given the advanced age of the donors. We found that BV/TV 
measured by micro-CT was comparable to previous studies that have evaluated similar 
regions and specimens of a similar age and gender [20, 45, 46]; preliminary in vivo HR-pQCT 
measurements suggest derived BV/TVs of up to 26% (unpublished data) and this is likely to 
be greater in a younger cohort. Assessment of calcaneus cortical bone was not undertaken 
due to the extremely thin cortices observed in our cohort that affected the segmentation of the 
calcaneus cortical bone; whether this would be possible in younger specimens remains to be 
determined. Third, in an attempt to broaden the BV/TV range that was validated, we evaluated 
smaller cubic regions of interest [25, 30], potentially increasing errors between modalities that 
would have been lessened by comparisons of larger cross-sectional area. Fourth, micro-CT 
analysis primarily used a fixed threshold, which was adapted for 4 regions (same specimen). 
Others have used an adaptive threshold for all samples [23] and this may be a factor in 
differences between the studies. Finally, we used the first generation XtremeCT device 
(isotropic voxel size = 82 ȝP, spatial resolution = 127 to 154 ȝP [47]) that uses plate model-
assumptions to compute trabecular microstructure. The second generation XtremeCT device 
KDVDUHSRUWHGVXSHULRUVSDWLDOUHVROXWLRQLVRWURSLFYR[HOVL]H ȝPVSDWLDOUHVROXWLRQ 
 ȝP ZKLFK LQFOXGHV PRUH LQGHSHQGHQW PHDVXUHPHQWV DQG PD\ LPSURYH WKH GLUHFW
estimation of trabecular microstructure [48]. Furthermore, the field of view is slightly larger and 
the scan time is shorter, which may better accommodate the quantification of calcaneus 
trabecular microstructure in vivo. 
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5. Conclusion 
In summary, we have developed a protocol to scan the calcaneus using HR-pQCT that has 
achieved measurement correlation and accuracy comparable to previous validation studies 
performed at the distal radius and distal tibia. Here, scanning a superior region of the bone 
with a 200ms scan integration time for the quantification of trabecular microstructure is 
preferred, based on the proposed protocol and integration times investigated in this study. 
Investigating inferior regions of the calcaneus and using lower integration time appears 
inaccurate. However, future developments will include the testing of HR-pQCT integration 
times in vivo and determining measurement precision error, bearing in mind the potential for 
movement artifacts in longer scan durations. Such studies will determine whether calcaneus 
HR-pQCT scans could have a significant clinical utility in osteoporosis or podiatry research. 
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